Medistim

Changes in ownership structure in Medistims second largest shareholder Chr Salvesen & Chr Thamshavn's Communications Aktieselskab

The company is represented in the Medistim ASA board

through Bjørn Wiggen. Bjørn Wiggen is a shareholder

and chairman of Thams Invest AS and Chairman of Chr

Salvesen & Chr Thams Communications Aktieselskab and

Salvesen & Thams Løkken AS.

Boards of Chr Salvesen & Chr Thams Communications

Aktieselskab and the holding company Thams Invest AS

has decided to transfer ownership of its 1,862,500

shares in Medistim ASA from Chr Salvesen & Chr Thams

Communications Aktieselskab to Thams Invest AS.

The transaction is part of a larger reorganization of

the business which was originally located in Chr

Salvesen & Chr Thamshavn's Communications

Aktieselskab. There will be a breakdown of the

various business areas within Chr Salvesen & Chr

Thamshavn's Communications Aktieselskab, where the

part of the business which includes investments is

moved to Thams Invest AS.

The transaction will be implemented in two steps.

First there is a demerger where the Medistim shares

will be transferred to the sister company Salvesen &

Thames Løkken AS. Thereafter a parent-subsidiary

merger is performed, which moves the ownership of the

Medistim shares to Thams Invest AS.

The General Meeting of Chr Salvesen & Chr Thams

Communications Aktieselskab and Salvesen & Thams

Løkken AS held the 25th of June 2014, decided the

demerger and the transfer the Medistim ASA shares to

Salvesen & Thames Løkken AS. The Board of Thams

Invest AS and Salvesen & Thames Løkken AS decided the

25th of June 2014 a parent-subsidiary merger.

The transactions are assumed done in the last half of

August 2014, after the creditor notification period

is over.

AI Terminal